IDH1 and cholangiocarcinoma: L-2HG was also found to be elevated in serum from patients with PDAC [52], and circulating 2HG has been proposed as a potential biomarker for IDH-mutant intrahepatic cholangiocarcinoma and cholangiocarcinoma [53,54].